<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01643525</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00069985</org_study_id>
    <nct_id>NCT01643525</nct_id>
  </id_info>
  <brief_title>Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke</brief_title>
  <official_title>A NonRandomized, Multicenter, NonSig Risk Study With a NonInv, Passive PressureWave Method of Diagnosing Cerebral Anomalies to Develop a Diag. Algorithm for Cerebral Isch and to Test Sens./Spec. of This Algorithm in Determining Isch Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jan Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jan Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      That the Jan Medical Nautilus NeuroWaveTM system provides significantly higher sensitivity to&#xD;
      hyper acute ischemic stroke than does CT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In spite of the fact that approximately 800,000 strokes are diagnosed in the United States&#xD;
      each year, many physicians and patients have approached the management of stroke with a sense&#xD;
      of futility. However, within the past 2 decades, following the advent of computerized&#xD;
      tomography (CT), medical interest has turned toward stroke and effective interventions to&#xD;
      treat and prevent it have received attention.&#xD;
&#xD;
      CT and/or magnetic resonance imaging (MRI) are the typical diagnostic tools used in the event&#xD;
      of a stroke alert. These studies are done on an emergent or urgent basis, since, to be&#xD;
      effective, treatments for ischemic and hemorrhagic stroke must be delivered soon after onset&#xD;
      of the illness. In an effort to institute an appropriate therapeutic regime, laboratory and&#xD;
      structural diagnostic studies are required to be done as rapidly as possible to determine&#xD;
      pathological etiology, size, and location of concern.&#xD;
&#xD;
      The speed at which a diagnosis is made and a treatment plan established often determines&#xD;
      patient outcome and any associated complications. This is especially true when evaluating&#xD;
      patients for ischemic stroke where there is a narrow 3 hour window of opportunity in which to&#xD;
      resolve the clot with IV .before permanent neurological impairment results, and up to 8&#xD;
      additional hours with the use if intra arterial (IA) t-PA or interventional mechanical&#xD;
      embolectomy procedures are utilized. Current treatment modalities include pharmacologic&#xD;
      thrombolytic drugs utilized to disrupt or dissolve clots located in the distal vasculature or&#xD;
      mechanical intervention in larger vessels. Since many patients do not recognize the symptoms&#xD;
      of stroke they do not seek medical attention immediately. Significant time is then often lost&#xD;
      from the onset of the stroke before seeking medical help / treatment.&#xD;
&#xD;
      Although the current technologies are quite adequate as diagnostic tools for hemorrhagic&#xD;
      stroke and for identifying subdural hematomas, and other pooled blood abnormalities which&#xD;
      would preclude t-PA therapy, they are largely ineffective at positively identifying stroke&#xD;
      during the limited therapeutic window of time. Positive identification of ischemia itself is&#xD;
      rarely possible or practical with CT or within the limited therapeutic window. As such the&#xD;
      diagnostic determination and associated treatment decisions are based on the unsatisfactory&#xD;
      basis of exclusion.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient Subject Recruitment&#xD;
  </why_stopped>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity, Specificity and Predictive Values of the Jan Medical DC1 System in Detecting Ischemia Within 12 Hours of Known Stroke Onset in Comparison to Follow up CT and MRI.</measure>
    <time_frame>At study completion- approximately 8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the Location to Left, Right, Deep, and/or Back of the Cranium</measure>
    <time_frame>At study completion- approximately 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Device Related Adverse Events</measure>
    <time_frame>At study completion- approximately 8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nautilus NeuroWaveTM Recording in MRI Normal Population (no Cerebrovascular Disease Per MRI)</measure>
    <time_frame>At study completion- approximately 8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Nautilus NeuroWave Recording Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nautilus NeuroWaveTM System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nautilus NeuroWaveTM System</intervention_name>
    <description>Non-invasive device designed to detect pressure signals from the skull to aid in the diagnosis of ischemic stroke.</description>
    <arm_group_label>Nautilus NeuroWave Recording Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptoms consistent with stroke with known onset &lt; 12 hours prior to enrollment and&#xD;
             planned recording with the Nautilus NeuroWave System&#xD;
&#xD;
          -  Suspected pathology of following vessels: internal carotid artery, ACA, MCA, PCA,&#xD;
             basilar or other anterior or posterior cerebral vessels or normal anatomy&#xD;
&#xD;
          -  Subject is planned to undergo standard stroke triage imaging protocol&#xD;
&#xD;
          -  Able to understand and provide signed informed consent, or have a Legally Authorized&#xD;
             Representative willing to provide informed consent on subject's behalf&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known to meet hospital criteria for brain death&#xD;
&#xD;
          -  Not a candidate for CT, MRI&#xD;
&#xD;
          -  unknown time of stroke symptom onset.&#xD;
&#xD;
          -  Psychologically unstable and not able to cooperate&#xD;
&#xD;
          -  Not suitable for participation in this study in the opinion of the Investigator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Nyquist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205-1911</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Bayview Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Howard County General Hospital</name>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <zip>21044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>June 29, 2012</study_first_submitted>
  <study_first_submitted_qc>July 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2012</study_first_posted>
  <results_first_submitted>June 2, 2015</results_first_submitted>
  <results_first_submitted_qc>June 2, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 19, 2015</results_first_posted>
  <last_update_submitted>June 2, 2015</last_update_submitted>
  <last_update_submitted_qc>June 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ischemic Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Nautilus NeuroWave Recording Arm</title>
          <description>Nautilus NeuroWaveTM System&#xD;
Nautilus NeuroWaveTM System: Non-invasive device designed to detect pressure signals from the skull to aid in the diagnosis of ischemic stroke.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nautilus NeuroWave Recording Arm</title>
          <description>Nautilus NeuroWaveTM System&#xD;
Nautilus NeuroWaveTM System: Non-invasive device designed to detect pressure signals from the skull to aid in the diagnosis of ischemic stroke.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.3" spread="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Females Known</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Males Known</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sensitivity, Specificity and Predictive Values of the Jan Medical DC1 System in Detecting Ischemia Within 12 Hours of Known Stroke Onset in Comparison to Follow up CT and MRI.</title>
        <time_frame>At study completion- approximately 8 months</time_frame>
        <population>Terminated study, data incomplete. Data not analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Nautilus NeuroWave Recording Arm</title>
            <description>Nautilus NeuroWaveTM System&#xD;
Nautilus NeuroWaveTM System: Non-invasive device designed to detect pressure signals from the skull to aid in the diagnosis of ischemic stroke.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity, Specificity and Predictive Values of the Jan Medical DC1 System in Detecting Ischemia Within 12 Hours of Known Stroke Onset in Comparison to Follow up CT and MRI.</title>
          <population>Terminated study, data incomplete. Data not analyzed.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Determine the Location to Left, Right, Deep, and/or Back of the Cranium</title>
        <time_frame>At study completion- approximately 8 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Device Related Adverse Events</title>
        <time_frame>At study completion- approximately 8 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nautilus NeuroWaveTM Recording in MRI Normal Population (no Cerebrovascular Disease Per MRI)</title>
        <time_frame>At study completion- approximately 8 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Nautilus NeuroWave Recording Arm</title>
          <description>Nautilus NeuroWaveTM System&#xD;
Nautilus NeuroWaveTM System: Non-invasive device designed to detect pressure signals from the skull to aid in the diagnosis of ischemic stroke.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Paul Nyquist</name_or_title>
      <organization>Johns Hopkins University</organization>
      <email>pnyquis1@jhmi.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

